Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of Asthma
Sponsor: Cuiling Feng
Summary
For patients with poor asthma control, on the basis of treatment guided by GINA guidelines, lung-benefiting moxibustion treatment will be given, and it will be applied 10 days before "early onset", once every 10 days, and the follow-up was 45 weeks, 1 cycle per year, for 2 consecutive cycles (2 years). The annual number of flare-up of asthma patients will be used as the main outcome index to evaluate the clinical effect of lung-benefiting moxibustion on reducing exacerbations of asthma. By observing immunoglobulin, T cell subsets and other indicators, the advantage population and mechanism of moxibustion in treating patients with poor asthma control will be clarified.
Official title: Clinical Study on Reducing Exacerbations of Asthma by Lung-benefiting Moxibustion Based on "Winter Disease Cured in Summer"
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
384
Start Date
2025-07
Completion Date
2027-08
Last Updated
2025-01-15
Healthy Volunteers
No
Conditions
Interventions
lung-benefiting moxibustion
A kind of external treatment，the treatment theory is to treat winter diseases in summer.
The specific drug comes from "GINA (2024)"
Refer to "GINA (2024)".